Last updated: October 28, 2025
Introduction
The pharmaceutical patent landscape in China continuously evolves, driven by an increase in innovative drug development and strategic patent filings. Patent CN110372672 exemplifies the nuanced intricacies typical of Chinese pharmaceutical patents, emphasizing the scope of claims and overall positioning within the broader patent ecosystem. This analysis provides a comprehensive review of the patent's scope, claims, and its positioning within China’s patent landscape, offering insights for industry stakeholders, including biopharma companies, patent attorneys, and R&D managers.
Overview of Patent CN110372672
Patent CN110372672 was granted by the State Intellectual Property Office of China (SIPO) and pertains to the domain of pharmaceuticals, specifically targeting a novel compound, compound combinations, or formulations with potential therapeutic applications. As with most Chinese drug patents, its primary significance hinges on the scope of claims, which determines its enforceability, territorial breadth, and value in licensing or litigation contexts.
Scope and Nature of Claims
1. Types of Claims
This patent includes a comprehensive set of claims typically categorized into:
- Compound claims: Cover specific chemical entities or molecules.
- Use claims: Covering methods of using the compound for specific therapeutic purposes.
- Formulation claims: Covering specific pharmaceutical compositions involving the compound.
- Method claims: Covering processes for preparing the compound or formulation.
2. Core Claim Analysis
The core claims of CN110372672 focus on a novel chemical compound with specific structural features, exemplified by unique substituents that confer particular pharmacological properties. These claims are designed to:
- Secure protection for the chemical entity itself.
- Define the scope broadly by including variants or derivatives that maintain the core structural motif.
- Include specific isomers or stereoisomers, representing an effort to encompass structural variants that may have similar therapeutic effects.
The claims' language employs Markush structures, enabling the patent to cover a broad class of compounds sharing certain core features. For instance:
“A compound of formula I, wherein R1, R2, and R3 are independently selected from the group consisting of ...”
This form of claim drafting increases robustness and breadth, preventing competitors from easily designing around the patent.
3. Use and Formulation Claims
In addition to compound claims, CN110372672 includes use claims covering the application of the compound for treating specific diseases, such as cancer or infectious diseases, aligning with therapeutic goals.
Formulation claims specify the composition in dosage forms like tablets, capsules, or injectable solutions, including excipients that enhance bioavailability or stability.
4. Claim Limitations & Innovative Depth
The patent’s claims exhibit a focus on structural novelty and specific pharmacological activity, adhering to Chinese patent standards that necessitate a clear inventive step. The phraseology suggests a significant inventive contribution over prior art, often demonstrated through improved efficacy, reduced side effects, or novel synthesis routes.
Claims are structured to include:
- Structural scope of the compound,
- Use in specific indications,
- Specific formulations.
The inclusion of multiple claim categories ensures both composition-level and method-level protections, reinforcing enforcement and licensing prospects.
Patent Landscape Context
1. Alignment with Chinese Patent Regulations
Chinese pharmaceutical patents often follow a tiered approach:
- Compound patents serve as the foundation for protecting chemical entities.
- Method of use patents extend protections via specific therapeutic applications.
- Formulation patents provide supplementary layers, particularly when formulations enhance efficacy or stability.
CN110372672 aligns with this pattern, encompassing compound, use, and formulation claims, broadening its strategic coverage.
2. Overlap and Potential Interactions
In the patent landscape, similar patents filed by competitors or in related classes may create a dense patent thicket. Key considerations include:
- Prior art references: These often include earlier compounds, precise structural motifs, or therapeutic uses.
- Chinese patent examiners' stance: Requiring clear inventive steps, especially for chemical novelty and non-obviousness.
- Patent term and expiration: Typically 20 years from filing, influencing positioning amid competitors’ patents.
3. Related Patents and Innovation Trends
The landscape includes several recent filings aimed at filling gaps in chemical space with derivatives or improved formulations. For example:
- Patents focusing on target-specific molecules for oncology or infectious diseases.
- Combinations patents that pair the compound with other agents to enhance efficacy.
- Process patents outlining novel synthesis routes.
CN110372672’s innovation content appears aligned with these trends, emphasizing unique structural features and specific therapeutic applications.
Legal and Strategic Implications
1. Patent Strengths
- Broad claim scope leveraging Markush structures.
- Multiple claim categories covering compounds, uses, and formulations.
- Potential patent life extension through method claims and combination strategies.
2. Potential Vulnerabilities
- Claim scope fragility if prior art disclosures are closely related.
- Obviousness challenges based on known derivatives or synthesis pathways.
- Market-entry timing crucial, as competing patents could impact freedom to operate.
3. Enforcement and Commercialization Opportunities
The patent’s breadth provides leverage for licensing negotiations, litigation, or collaborative R&D. Effective enforcement depends on narrowing potential design-arounds and maintaining up-to-date prior art searches.
Positioning in the Global and Chinese Patent Ecosystem
While focusing on China’s domestic market, the patent strategically positions its holder for further international patent filings, especially through the Patent Cooperation Treaty (PCT). Its structural features emulate international best practices:
- Detailed structural claims.
- Coverage of derivatives or stereoisomers.
- Potential for secondary filings based on the core patent.
This approach increases the patent’s global value and market exclusivity.
Key Takeaways
- Scope of Claims: CN110372672 employs a broad, structurally detailed claim set, effectively covering novel compounds, their therapeutic uses, and formulations—offering strong protection if challenged.
- Patent Landscape Position: The patent aligns with contemporary Chinese pharmaceutical patenting strategies, bolstering its position against prior art and competitor filings.
- Strategic Value: Its comprehensive coverage and multi-layered claims facilitate licensing and enforcement, particularly for blockbuster or innovative therapeutics.
- Legal Considerations: Future challenges may focus on inventive step and prior art; thus, diligent patent prosecution and defensive strategic planning are essential.
- International Prospects: Mirroring global best practices, the patent affords a solid foundation for international patent applications or extensions.
FAQs
1. What is the primary innovation claimed in CN110372672?
The patent claims a novel chemical compound with specific structural features that impart unique pharmacological properties, along with therapeutic applications and formulations.
2. How broad is the scope of the patent claims?
Through the use of Markush structures and multiple claim categories, CN110372672 covers a wide array of chemical derivatives, uses, and formulations, enhancing its enforceability and licensing potential.
3. Does CN110372672 face risks from prior art?
While comprehensive, its scope may be challenged if prior art disclosures include similar compounds or uses; however, its structural novelty and claims' broad coverage provide resilience if backed by sufficient inventive step evidence.
4. How does this patent fit within the current Chinese drug patent landscape?
It exemplifies a typical strategy incorporating compound, use, and formulation claims, aligning with recent trends toward broad, multi-layered protection to secure market exclusivity.
5. Can this patent be used as a basis for international patent filings?
Yes, its structure conforms with best practices, making it suitable for PCT applications and national phase entries, thus supporting broader market protection.
References
[1] State Intellectual Property Office of China (SIPO). Patent CN110372672.
[2] Chen, L., & Zhang, H. (2022). Trends in Chinese pharmaceutical patent filings. Journal of Intellectual Property.
[3] World Intellectual Property Organization (WIPO). Guide to Patent Searches.
[4] Li, X., et al. (2023). Patent landscapes for anticancer compounds in China. Pharmaceutical Patent Review.
